Potential IPF Treatment BBT-877 Safe, Lowers Blood Levels of Fibrotic Molecule, Phase 1 Trial Data Show
News
The idiopathic pulmonary fibrosis (IPF) treatment candidate BBT-877 is safe and well-tolerated in healthy volunteers, and markedly reduced the plasma levels of a lipid molecule involved in inflammation and ... Read more